RBC Life Sciences Inc. reported earnings results for the first quarter of 2013. For the quarter, the company reported consolidated net sales of $5.7 million for the first quarter ended March 31, 2013, a 6% decrease over the first quarter ended March 31, 2012. The company reported a net loss of $8,000, or $0.00 per diluted share, compared to a net loss of $73,000, or $0.00 per diluted share, during the first quarter of 2012.

Operating income was $23,000 compared to operating loss of $87,000 a year ago. Loss before income taxes was $6,000 compared to $120,000 a year ago.